The following is a summary of “An integrative multi-omics analysis reveals a multi-analyte signature of pancreatic ductal ...

NewAmsterdam Pharma's obicetrapib demonstrates strong phase 3 results. Discover why NAMS stock could rise as further studies ...

Conversely, among the 37 human metabolites were found to reduce the risk of coronary atherosclerosis, the following were included: Cholesteryl esters to total lipids ratio in medium HDL: The OR for ...